57 related articles for article (PubMed ID: 1743531)
1. Benign symptomatic hyperandrogenism in a postmenopausal woman.
Cowan BD; Moore JL; Whitworth NS; Wiser WL
Geriatrics; 1991 Dec; 46(12):57-8, 63. PubMed ID: 1743531
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
Elkind-Hirsch KE; Anania C; Malinak R
J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
[TBL] [Abstract][Full Text] [Related]
3. Diffuse stromal Leydig cell hyperplasia: a unique cause of postmenopausal hyperandrogenism and virilization.
Taylor HC; Pillay I; Setrakian S
Mayo Clin Proc; 2000 Mar; 75(3):288-92. PubMed ID: 10725957
[TBL] [Abstract][Full Text] [Related]
4. Hair loss in women.
Camacho-Martínez FM
Semin Cutan Med Surg; 2009 Mar; 28(1):19-32. PubMed ID: 19341939
[TBL] [Abstract][Full Text] [Related]
5. Use of a gonadotropin-releasing hormone agonist in the evaluation of postmenopausal virilization due to ovarian hyperthecosis. A case report.
Koroscil TM; Harter SB; Ouweleen J; Blauer KL
J Reprod Med; 1996 Apr; 41(4):259-62. PubMed ID: 8728079
[TBL] [Abstract][Full Text] [Related]
6. Sex hormone status in women suffering from rheumatoid arthritis.
Cutolo M; Balleari E; Giusti M; Monachesi M; Accardo S
J Rheumatol; 1986 Dec; 13(6):1019-23. PubMed ID: 3104587
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone agonist treatment in postmenopausal women with hyperandrogenism of ovarian origin.
Vollaard ES; van Beek AP; Verburg FA; Roos A; Land JA
J Clin Endocrinol Metab; 2011 May; 96(5):1197-201. PubMed ID: 21307133
[TBL] [Abstract][Full Text] [Related]
8. Virilization in bilateral macronodular adrenal hyperplasia controlled by luteinizing hormone.
Goodarzi MO; Dawson DW; Li X; Lei Z; Shintaku P; Rao CV; Van Herle AJ
J Clin Endocrinol Metab; 2003 Jan; 88(1):73-7. PubMed ID: 12519832
[TBL] [Abstract][Full Text] [Related]
9. Hirsutism and virilism in women.
Kirschner MA
Spec Top Endocrinol Metab; 1984; 6():55-93. PubMed ID: 6084314
[TBL] [Abstract][Full Text] [Related]
10. Hyperandrogenism in a postmenopausal woman: diagnostic and therapeutic challenges.
Cheng V; Doshi KB; Falcone T; Faiman C
Endocr Pract; 2011; 17(2):e21-5. PubMed ID: 21247854
[TBL] [Abstract][Full Text] [Related]
11. Steroid hormones and gonadotropins in a case of ovarian endometriosis associated with virilization.
Mango D; Manna P; Liberati M; Benedetto MT; Ricci S; Olleja L; de Cicco Nardone F; Menini E
Acta Obstet Gynecol Scand; 1992 Feb; 71(2):153-5. PubMed ID: 1316048
[TBL] [Abstract][Full Text] [Related]
12. Androgen-secreting steroid cell tumor of the ovary.
Powell JL; Dulaney DP; Shiro BC
South Med J; 2000 Dec; 93(12):1201-4. PubMed ID: 11142457
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
Blank SK; McCartney CR; Helm KD; Marshall JC
Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
[TBL] [Abstract][Full Text] [Related]
14. A gonadotrophin dependent stromal luteoma: a rare cause of post-menopausal virilization.
Chico A; García JL; Matías-Guiu X; Webb SM; Rodríguez J; Prat J; Calaf J
Clin Endocrinol (Oxf); 1995 Nov; 43(5):645-9. PubMed ID: 8548951
[TBL] [Abstract][Full Text] [Related]
15. Effects of short-term suppression of ovarian hormones on cardiovascular and neuroendocrine reactivity to stress in women.
Matthews KA; Berga SL; Owens JF; Flory JD
Psychoneuroendocrinology; 1998 May; 23(4):307-22. PubMed ID: 9695133
[TBL] [Abstract][Full Text] [Related]
16. Response of a mucinous ovarian tumor of borderline malignancy to human chorionic gonadotropin.
Quinn MA; Baker HW; Rome R; Fortune D; Brown JB
Obstet Gynecol; 1983 Jan; 61(1):121-6. PubMed ID: 6401852
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
[TBL] [Abstract][Full Text] [Related]
18. Ovarian and adrenal steroidogenesis in a virilized patient with gonadotropin-resistant ovaries and hilus cell hyperplasia.
Meldrum DR; Frumar AM; Shamonki IM; Benirschke K; Judd HL
Obstet Gynecol; 1980 Aug; 56(2):216-21. PubMed ID: 7393511
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of a GnRH agonist, leuprolide acetate, into regimens with exogenous gonadotropins to produce ovarian stimulation and ovulation in the nonpregnant squirrel monkey.
Kuehl TJ; Davis TW; Young C; Nunez P; Robinson MR; Huddleston KP; Wincek TJ; Pliego JF; Dukelow WR
Am J Primatol; 1999 Oct; 49(2):153-64. PubMed ID: 10466574
[TBL] [Abstract][Full Text] [Related]
20. A gonadotrophin responsive testosterone producing adrenocortical adenoma and high gonadotrophin levels in an elderly woman.
de Lange WE; Pratt JJ; Doorenbos H
Clin Endocrinol (Oxf); 1980 Jan; 12(1):21-8. PubMed ID: 6769610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
